Gestrinone 98.0%
98.0%
Properties
| Assay Purity | >98% |
| Refractive index | 1.607 |
| B pt. | 507.6℃ at 760mmHg |
| M pt. | 152℃ |
| Density | 1.18g/cm3 |
Safety Information
| Hazard Statement(s) | H361 |
| Precautionary Statement | P501-P202-P201-P280-P308 + P313-P405 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 214.9℃ |
| Storage Temp. | 0-10℃ |
| Packaging | Glass Bottle |
Description
Recommended products
2-Methoxypyridine 98%
Application
Gestrinone is described as similar in action and effect to danazol which is also used in the treatment of endometriosis but is reported to have fewer androgenic side effects in comparison. Because of its anabolic effects the use of gestrinone in competition has been banned by the International Olympic Committee.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Gestrinone (INN USAN BAN) (brand names Dimetriose Dimetrose Nemestran) also known as ethylnorgestrienone (i.e. ethyl derivative of norgestrienone) is a synthetic steroid of the 19-nortestosterone group that is marketed in Europe Australia and Latin America though not the United States and is used primarily in the treatment of endometriosis. It is a potent mixed progestogen and antiprogestogen (i.e. partial agonist of the progesterone receptor (PR) or selective progesterone receptor modulator (SPRM)) an antigonadotropin a mild androgen and anabolic steroid and a functional antiestrogen.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |
